Molecular &
Experimental Surgey (MES)

Refining SurgeryWe are Translating the Language of Stem Cells and Peripheral Nervous System to Expand the Toolbox in Minimal Invasive Surgery and to Produce Personalized Therapies.

Scientist using scalpel in lab

What is MES?

MES is the transdisciplinary answer to combat unmet clinical needs in visceral and hepatobiliary medicine with a special focus on aiming to improve the performance and endurance of patient care involving surgery. As an independent department, MES is embedded in the University Clinic for General-, Visceral- and Vascular Surgery at Otto-von-Guericke University (chairman Roland S Croner, a global opinion maker in robotic surgery). Our daily mission is inspired by clinical problems occurring in real-world situations before, during or after surgical interventions. MES focuses primarily – but not exclusively- on cancer research.

How do we harness it?

MES platform combines core technological and scientific components to reveal new insights into disease. Fueled by these discoveries we identify advanced starting points for innovating patient care.

  • stem cell culture technologies
  • genetic engineering
  • clinical specimen biobank
  • AI
  • science integrety

Why do we care?

Surgery is the therapy of choice for most of the malignant diseases, generally resulting in clinical positive prognostic outcomes. MES builds on this foundation to optimize the management of patients obtaining surgery by:

  • increasing long-term durability of therapy outcomes of oncological surgery
  • optimizing performance of surgery robotic
  • reducing the burden of off-target effects of (neo)adjuvant therapies